Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
AYTU
#4459
Aytu BioPharma, Inc. - Common Stock
2.0
3
USD
+0.03%
Market Price
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+3.05%
Monthly Change
-2.87%
6 month change
-23.11%
Year Change
-12.50%
Previous Close
1.9
7
Open
2.0
1
Low
1.9
8
High
2.0
3
Markets
US Stock Market
Healthcare
Drug Manufacturers—Specialty & Generic
AYTU
1D
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Documents
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
Current
Key stats
Total common shares outstanding
1.38 M
3.12 M
5.53 M
6.15 M
9.91 M
10.87 M
10.87 M
Valuation ratios
Enterprise value
88.4 M
23.72 M
-14.14 M
12.65 M
1.55 M
8.01 M
7.29 M
Price to earnings ratio
—
-0.18
-0.31
1
-1.01
-1.86
-1.8
Price to sales ratio
—
0.21
0.05
0.19
0.21
0.46
0.45
Price to cash flow ratio
—
0.7
1.04
11.37
-7.07
8.07
7.82
Price to book ratio
—
0.44
0.14
0.57
0.72
0.75
0.73
Enterprise value to EBITDA ratio
-1.78
-0.23
1.71
4.19
-1.35
0.68
-1.69
Profitability ratios
Return on assets %
-0.22
-0.8
-0.12
-0.13
-0.11
-0.14
-0
Return on equity %
-0.42
-2.39
-0.43
-0.57
-0.72
-0.4
-0
Return on invested capital %
-164.04
-299.93
-74.28
-27.24
-54.48
-64.78
-21.53
Gross margin %
44.49
54.08
62.04
67.39
69.04
63.95
64.63
Operating margin %
-89.7
-115.41
-15.89
-6.49
-11.79
-14.44
-4.82
EBITDA margin %
-75.68
-104.8
-7.68
3.73
-3.81
-7.48
11.6
Net margin %
-88.81
-113.97
-15.88
-19.56
-20.43
-24.76
-0.09
Liquidity ratios
Quick ratio
0.81
0.76
0.88
1.79
1.07
1
1
Current ratio
0.96
0.93
1.06
1.99
1.26
1.13
1.13
Inventory turnover
0.56
0.16
3.57
2.15
1.8
3.03
0.8
Asset turnover
0.31
0.48
0.78
0.64
0.53
0.55
0.15
Solvency ratios
Debt to assets ratio
—
—
—
0.09
0.09
0.1
0.1
Debt to equity ratio
—
—
—
0.39
0.57
0.31
0.31
Long term debt to total assets ratio
0.06
0.11
0.11
0.11
0.1
0.1
0.1
Long term debt to total equity ratio
0.12
0.33
0.38
0.46
0.67
0.31
0.31
Per share metrics
Operating cash flow per share
—
-19.61
-1.54
-0.25
-0.31
0.27
0.27
EBIT per share
—
-75.9
-5.11
-0.95
-1.25
-0.67
-0.67
EBITDA per share
—
-68.92
-2.47
0.54
-0.4
-0.35
-0.35
Total debt per share
—
—
—
2.73
1.73
0.89
0.89
Cash per share
—
13.17
6.88
3.61
4.93
2.14
2.14
Net current asset value per share
—
40.77
21.81
22.35
12.61
5.01
5.01
Tangible book value per share
—
31.36
11.78
-4.47
-3.7
-0.5
-0.5
Working capital per share
—
-3.07
1.14
11.11
2.57
0.58
0.58
Book value per share
—
31.36
11.78
5
3.02
2.86
2.86
News
Elite Pharmaceuticals vs. Aytu: Which CNS Stock Is the Better Buy?
Microsoft To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Wednesday
Ascendiant Capital Maintains Buy on Aytu BioPharma, Raises Price Target to $15
Transcript: Aytu BioPharma Q4 2026 Earnings Conference Call
Aytu BioPharma, Inc. (AYTU) Reports Q4 Loss, Beats Revenue Estimates
Aytu BioPharma Q4 EPS $0.00 and Sales $16.106M Beat $12.276M Estimate
Earnings Scheduled For September 22, 2026
HeartSciences Inc. (HSCS) Reports Q1 Loss, Misses Revenue Estimates
New Strong Sell Stocks for July 20th
New Strong Sell Stocks for July 16th
Aytu BioPharma, Inc. (AYTU) Q3 2026 Earnings Call Transcript
Aytu BioPharma, Inc. (AYTU) Reports Q3 Loss, Tops Revenue Estimates